Nureca Ltd

₹ 326 -2.03%

13 Oct 4:01 p.m.

About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.^[1]

Key Points

Business Overview:^[1]^[2]
NL is a digitally first, consumer healthcare company with presence in categories such
as home diagnostics, wellness devices, and personal fitness equipment under brands like
Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26

Website BSE NSE - BE

Market Cap ₹ 311 Cr.
Current Price ₹ 326
High / Low ₹ 376 / 200
Stock P/E 143
Book Value ₹ 186
Dividend Yield 0.00 %
ROCE 2.07 %
ROE 0.16 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.

Cons

The company has delivered a poor sales growth of -7.15% over past five years.
Company has a low return on equity of -0.51% over last 3 years.
Earnings include an other income of Rs.7.65 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	21.23	31.35	22.37	19.56	23.31	32.37	27.21	31.75	34.32	37.84	39.64	35.41	40.40
	24.22	30.31	26.80	24.32	26.23	35.03	31.95	31.19	35.40	35.22	37.25	41.95	37.95
Operating Profit	-2.99	1.04	-4.43	-4.76	-2.92	-2.66	-4.74	0.56	-1.08	2.62	2.39	-6.54	2.45
OPM %	-14.08%	3.32%	-19.80%	-24.34%	-12.53%	-8.22%	-17.42%	1.76%	-3.15%	6.92%	6.03%	-18.47%	6.06%
	2.69	3.21	5.92	-1.25	5.82	3.21	1.52	2.00	2.59	2.38	2.29	1.06	1.92
Interest	0.11	0.08	0.10	0.17	0.13	0.25	0.14	0.59	0.20	0.41	0.18	0.24	0.18
Depreciation	0.56	0.56	0.56	0.56	0.61	0.57	0.49	0.48	0.48	0.48	0.46	0.43	0.57
Profit before tax	-0.97	3.61	0.83	-6.74	2.16	-0.27	-3.85	1.49	0.83	4.11	4.04	-6.15	3.62
Tax %	-22.68%	26.87%	90.36%	-34.57%	44.91%	140.74%	-14.55%	-38.93%	33.73%	23.60%	20.30%	7.80%	32.87%
	-0.74	2.64	0.08	-4.41	1.20	-0.65	-3.29	2.07	0.55	3.14	3.23	-6.63	2.43
EPS in Rs	-0.74	2.64	0.08	-4.41	1.20	-0.65	-3.29	2.07	0.55	3.14	3.39	-6.95	2.55
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017 5m	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	0	1	1	99	213	256	112	95	115	147	153
	0	1	1	90	152	200	127	106	124	150	152
Operating Profit	0	0	0	10	62	56	-15	-11	-10	-3	1
OPM %	0.0%	3.4%	4.1%	10%	29%	22%	-14%	-12%	-8%	-1.8%	0.6%
	0	0	0	0	3	8	7	11	13	8	8
Interest	0	0	0	1	2	1	0	0	1	1	1
Depreciation	0	0	0	0	0	1	2	2	2	2	2
Profit before tax	0	0	0	9	62	61	-11	-3	-0	3	6
Tax %		50%	33%	26%	26%	26%	-23%	-25%	46%	90%
	0	0	0	6	47	45	-8	-2	-1	0	2
EPS in Rs	0.00	20.00	20.00	6,410.00	46.53	45.31	-8.42	-2.44	-0.67	0.31	2.13
Dividend Payout %		0%	0%	0%	4%	7%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	-7%
3 Years:	10%
TTM:	22%

Compounded Profit Growth
10 Years:	%
5 Years:	-64%
3 Years:	27%
TTM:	264%

Stock Price CAGR
10 Years:	%
5 Years:	-29%
3 Years:	-2%
1 Year:	40%

Return on Equity
10 Years:	8%
5 Years:	4%
3 Years:	-1%
Last Year:	0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.01	0.01	0.01	0.01	10	10	10	10	10	10
Reserves	0	0	0	15	153	194	185	183	182	168
	0	0	0	10	4	4	3	2	4	2
	0	0	1	9	19	11	8	9	10	14
Total Liabilities	0	0	1	34	186	220	207	204	206	194
	0	0	0	1	3	10	8	6	8	12
CWIP	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	1	34	62	97	4	4
	0	0	1	33	181	175	136	101	194	177
Total Assets	0	0	1	34	186	220	207	204	206	194

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-8	35	2	12	-3	-19	0
	0	-0	-110	-3	-18	18	9	16
	0	8	92	-7	-2	-1	-1	-19
Net Cash Flow	0	-0	17	-9	-8	14	-11	-2
Free Cash Flow	-0	-8	35	-4	12	-4	-23	-5
CFO/OP		-81%	81%	35%	-107%	40%	183%	4%

Ratios

Standalone / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	365	87	65	47	0	4	14	7	14	24
Inventory Days	0	101	590	93	135	174	154	156	163	162
Days Payable		233	849	33	32	13	23	27	26	23
Cash Conversion Cycle	365	-45	-195	107	103	165	145	136	151	164
Working Capital Days	182	-12	-45	85	61	109	148	160	145	132
ROCE %		100%	75%	76%	67%	33%	-5%	-1%	0%	2%

Insights

In beta

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Cumulative Online Customer Base
thousands

x,xxx	x,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
	x.xx	x.xx	x.xx	xx.xx	xx.xx	xx.xx
	xxx	xxx		xxx	xxx	xxx
			x.xx	x.xx	x.xx	x.xx
		xxx		xxx	xxx	xxx
	xx			xx	xx	xx
		xx			xx	xx
						xxx,xxx

Please log in to see hidden values.

Manufacturing Subsidiary (NTPL) Sales
INR Crore

Active SKUs
count

Dr Trust 360 App Users
millions

Live Distributors
count

Online Revenue Contribution
%

Live States & Union Territories
count

Manufacturing Annual Capacity
units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

30 Recently

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	63.24%	63.24%	63.24%	63.24%	63.78%	64.06%	64.30%	64.33%	64.97%	64.97%	68.09%	68.09%
	0.10%	0.07%	0.07%	0.07%	0.69%	0.36%	1.07%	0.07%	0.07%	0.08%	0.28%	0.11%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%	0.04%	0.04%	0.24%	0.24%
	36.67%	36.69%	36.69%	36.69%	35.53%	35.54%	34.59%	35.56%	34.92%	34.91%	31.39%	31.57%
No. of Shareholders	52,255	49,600	45,996	43,813	41,986	41,314	39,304	38,075	37,468	35,801	34,558	33,979

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	70.00%	70.00%	62.98%	63.24%	64.30%	68.09%	68.09%
	10.51%	12.22%	0.10%	0.07%	1.07%	0.28%	0.11%
	8.09%	5.23%	0.00%	0.00%	0.04%	0.24%	0.24%
	11.40%	12.55%	36.91%	36.69%	34.59%	31.39%	31.57%
No. of Shareholders	7,827	26,123	58,560	45,996	39,304	34,558	33,979

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jul 2026

Transcript

AI Summary
PPT
May 2026

Transcript

AI Summary
PPT
Jan 2026

Transcript

AI Summary
PPT
Jan 2026

Transcript

AI Summary
PPT
Oct 2025

Transcript

AI Summary
PPT
Jul 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
Jan 2025

Transcript

AI Summary
PPT
Oct 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Nov 2023

Transcript

AI Summary
PPT
Aug 2023

Transcript

AI Summary
PPT